Avalanche Bio Downgraded At William Blair, Firm Says Phase IIb 'A Ways Away'

By: via Benzinga
In a report published Tuesday, William Blair analyst Tim Lugo downgraded the rating on Avalanche Biotechnologies Inc (NASDAQ: AAVL) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.